SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010278
Filing Date
2020-05-11
Accepted
2020-05-11 16:02:20
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20200331_10q.htm 10-Q 476330
2 EXHIBIT 31.1 ex_184627.htm EX-31.1 10662
3 EXHIBIT 31.2 ex_184628.htm EX-31.2 10530
4 EXHIBIT 32.1 ex_184629.htm EX-32.1 4867
5 EXHIBIT 32.2 ex_184630.htm EX-32.2 5571
  Complete submission text file 0001437749-20-010278.txt   2712809

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20200331.xml EX-101.INS 446933
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20200331.xsd EX-101.SCH 35647
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20200331_cal.xml EX-101.CAL 22836
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20200331_def.xml EX-101.DEF 218089
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20200331_lab.xml EX-101.LAB 209589
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20200331_pre.xml EX-101.PRE 237818
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 20864675
SIC: 2834 Pharmaceutical Preparations